Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Seronegativity”

383 trials

Showing 20 of 383 results

Not applicableStudy completedNCT02630082
What this trial is testing

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

Who this might be right for
HIV InfectionsAcquired Immunodeficiency SyndromeLentivirus Infections+8 more
National Institute of Allergy and Infectious Diseases (NIAID) 29
Large-scale testing (Phase 3)Study completedNCT00448669
What this trial is testing

Botswana TDF/FTC Oral HIV Prophylaxis Trial

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 1,219
Early research (Phase 1)Study completedNCT00000886
What this trial is testing

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)UnknownNCT00062530
What this trial is testing

Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 38
Not applicableStudy completedNCT00691561
What this trial is testing

Culturally-Tailored HIV Risk Reduction for African-American MSM

Who this might be right for
HIV Infections
Medical College of Wisconsin 220
Early research (Phase 1)Study completedNCT00043511
What this trial is testing

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)UnknownNCT00981695
What this trial is testing

Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers

Who this might be right for
HIV-1HIV Infections
Medical Research Council 72
Early research (Phase 1)Study completedNCT00000904
What this trial is testing

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT00441298
What this trial is testing

Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV

Who this might be right for
HIV Infections
Centre for the AIDS Programme of Research in South Africa 889
Early research (Phase 1)Study completedNCT00000972
What this trial is testing

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 64
Not applicableStudy completedNCT00279331
What this trial is testing

Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador

Who this might be right for
HIV InfectionsSyphilisSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 2,608
Not applicableStudy completedNCT00696618
What this trial is testing

Enema Use and Acceptability in HIV Negative Men Who Have Sex With Men

Who this might be right for
HIV Infections
Johns Hopkins University 9
Testing effectiveness (Phase 2)Study completedNCT00007332
What this trial is testing

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 330
Early research (Phase 1)Study completedNCT00002231
What this trial is testing

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Testing effectiveness (Phase 2)Study completedNCT00886561
What this trial is testing

HIV- Risk Reduction Behavioral Intervention for Commercial Sex Workers in Yerevan Armenia

Who this might be right for
HIV PreventionHIV Infections
Emory University 120
Not applicableStudy completedNCT00006324
What this trial is testing

Hormonal Birth Control and the Risk of Acquiring HIV

Who this might be right for
HIV Infections
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 6,360
Testing effectiveness (Phase 2)WithdrawnNCT00398008
What this trial is testing

HIV Risk Reduction and Drug Abuse Treatment in Iran

Who this might be right for
Opiate DependenceHIV Infections
Yale University
Large-scale testing (Phase 3)Study completedNCT00194519
What this trial is testing

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Who this might be right for
HIV InfectionHerpes Simplex, GenitalSexually Transmitted Diseases
University of Washington 3,408
Large-scale testing (Phase 3)Study completedNCT00639938
What this trial is testing

Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 722
Early research (Phase 1)Study completedNCT00001043
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation